Influence of dental filling material type on the concentration of interleukin 9 in the samples of gingival crevicular fluid

  • dr Vladimir Stefanović Clinic for Dental Medicine, Military Medical Academy, Belgrade, Serbia
  • Ervin Taso Clinic for Dental Medicine, Military Medical Academy, Belgrade, Serbia
  • Aleksandra Petković Ćurčin Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
  • Mirjana Djukić Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
  • Milka Gardašević Clinic for Maxilofacial Surgery,Military Medical Academy, Belgrade, Serbia
  • Mia Rakić Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
  • Struillou Xavier Department of Periodontology, University of Nantes, Nantes, France
  • Milena Jović Institute for Pathology, Military Medical Academy, Belgrade, Serbia
  • Karolina Miller Histopathology Department, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom
  • Ivan Stanojević Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
  • Danilo Vojvodić Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
Keywords: dental caries, dental materials, gingival cervicular fluid, cytokines, interleukin-9.,

Abstract



Background/Aim. Several cytokines and lymphokines (IL1β, ENA78, IL6, TNFα, IL8 and S100A8) are expressed during dental pulp inflammation. Analysis of gingival crevicular fluid (GCF) offers a non-invasive means of studying general host response in oral cavity. Although GCF levels of various mediators could reflect the state of inflammation both in dental pulp and gingiva adjacent to a tooth, GCF samples of those without significant gingivitis could be interpreted as reflection of pulpal process. The aim of this study was to investigate IL9 GCF values in patients with dental caries and to assess possible influence of various dental fillings materials on local IL9 production. Methods. The study group included 90 patients, aged 18–70, with inclusion and exclusion criteria in the prospective clinical study. Of the 6 types of material used for the restoration of prepared cavities, 3 were intended for temporary and 3 for definitive restoration. According to dental fillings weight, all the participants were divided into 3 groups: those with fillings lighter than 0.50 g, those with 0.50–1.00 g, and those with fillings heavier than 1.00 g. Samples were taken from gingival sulcus using the filter paper technique. Clinical parameters were determined by bleeding index, plaque index (Silness-Lou, 0–3), gingival index (0–3), and gingival sulcus depth. Cytokine concentrations were assessed using commercially available cytomix. Results. According to the weight of dental fillings, there was a clear decreament trend of IL9 values meaning that dental defects greater than 1.00 g of dental filling were associated with lower GCF IL9 concentration. The IL9 values correlated with the degree of gingival index and depth of gingival sulcus, being higher with more advanced gingivitis and more pronounced anatomical changes in the tooth edge. Different filling materials exerted various local IL9 responses. Zink polycarbonate cement and amalgam fillings induced a significant and long-lasting local IL9 decrement, while the use of Tetric EvoCeram and GMA-BISK significantly increased IL9 levels. Conclusion. The obtained results indicate that IL9 GCF could be regarded as a measure of odontoblasts’ response to the extensity of dental caries. The type of material used for dental fillings could profoundly alter biological function of gingival and pulpal cells. Also, the results obtained in this study suggest that some materials could even enhance wound repair by modulating macrophage activation.

References

McLachlan JL, Sloan AJ, Smith AJ, Landini G, Cooper PR. S100 and Cytokine Expression in Caries. Infect Immun 2004; 72(7): 4102−8.

Elsalhy M, Azizieh F, Raghupathy R. Cytokines as diagnostic markers of pulpal inflammation. Int Endod J 2013; 46(6): 573−80.

Adachi T, Nakanishi T, Yumoto H, Hirao K, Takahashi K, Mukai K, et al. Caries-related bacteria and cytokines induce CXCL10 in dental pulp. J Dent Res 2007; 86(12): 1217−22.

Artese L, Rubini C, Ferrero G, Fioroni M, Santinelli A, Piattelli A. Vascular endothelial growth factor (VEGF) expression in healthy and inflamed human dental pulps. J Endod 2002; 28(1): 20−3.

Kokkas AB, Goulas A, Varsamidis K, Mirtsou V, Tziafas D. Irre-versible but not reversible pulpitis is associated with up-regulation of tumour necrosis factor-alpha gene expression in human pulp. Int Endod J 2007; 40(3): 198−203.

Rauschenberger CR, Bailey JC, Cootauco CJ. Detection of human IL-2 in normal and inflamed dental pulps. J Endod 1997; 23(6): 366−70.

Karapanou V, Kempuraj D, Theoharides TC. Interleukin-8 Is In-creased in Gingival Crevicular Fluid from Patients with Acute Pulpitis. J Endod 2008; 34(2): 148−51.

Horst OV, Horst JA, Samudrala R, Dale BA. Caries induced cy-tokine network in the odontoblast layer of human teeth. BMC Immunol 2011; 12(1): 9.

Farges J, Keller J, Carrouel F, Durand SH, Romeas A, Bleicher F, et al. Odontoblasts in the dental pulp immune response. J Exp Zool B Mol Dev Evol B 2009; 312B(5): 425−36.

Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, et al. TGF-beta induces IL-9 production from human Th17 cells. J Immunol 2010; 185(1): 46−54.

Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003; 170(7): 3461−7.

Wiener Z, Falus A, Toth S. IL-9 increases the expression of sev-eral cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 2004; 26(3): 122−30.

Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, et al. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Exp Hematol 1994; 22(9): 919−23.

Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M, et al. Role of human interleukin-9 as a megakaryocyte potentia-tor in culture. Exp Hematol 2002; 30(12): 1373−80.

Steenwinckel V, Louahed J, Lemaire MM, Sommereyns C, Warnier G, McKenzie A, et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 2009; 182(8): 4737−43.

Yamasaki A, Saleh A, Koussih L, Muro S, Halayko AJ, Gounni AS. IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS One 2010; 5(2): e9178.

Pilette C, Ouadrhiri Y, van Snick J, Renauld JC, Staquet P, Vaerman JP, et al. IL9 inhibits oxidative burst and TNF-α release in li-popolysaccharide-stimulated human monocytes through TGF-β. J Immunol 2002; 168(8): 4103−11.

Fawaz LM, Sharif-Askari E, Hajoui O, Soussi-Gounni A, Hamid Q, Mazer BD. Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol 2007; 120(5): 1208−15.

Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, et al. IL-9 as a mediator of Th17-driven inflamma-tory disease. J Exp Med 2009; 206(8): 1653−60.

Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci USA 2009; 106(31): 12885−90.

Hültner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 1990; 20(6): 1413−6.

Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, et al. Interleukin 9 promotes influx and local maturation of eosino-phils. Blood 2001; 97(4): 1035−42.

Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000; 96(6): 2163−71.

Wilhelm C, Stockinger B. Innate Lymphoid Cells and Type 2 (Th2) Mediated Immune Responses - Pathogenic or Beneficial. Front Immunol 2011; 2: 68.

Love RM, Jenkinson HF. Invasion of dental tubules by oral bac-teria. Crit Rev Oral Biol Med 2002; 13(2): 171−83.

Farges J, Keller J, Carrouel F, Durand SH, Romeas A, Bleicher F, et al.. Odontoblasts in the dental pulp immune response. J Exp Zool B Mol Dev Evol 2009; 312B(5): 425−36.

Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. Biphasic Regulation of NF- B Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide. J Immunol 2001; 166(6): 3873−81.

di Maio FD, Lohinai Z, d`Arcangelo C, de Fazio PE, Speranza L, de Lutiis MA, et al. Nitric Oxide Synthase in Healthy and In-flamed Human Dental Pulp. J Dent Res 2004; 83(4): 312−6.

Takahashi K, Nakanishi T, Yumoto H, Adachi T, Matsuo T. CCL20 production is induced in human dental pulp upon stimulation by Streptococcus mutans and proinflammatory cytokines. Oral Microbiol Immunol 2008; 23(4): 320−7.

Wilhelm C, Turner J, van Snick J, Stockinger B. The many lives of IL-9: a question of survival. Nat Immunol 2012; 13(7): 637−41.

Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature 2012; 484(7395): 465−72.

Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013; 38(2): 360−72.

Gregersen I, Skjelland M, Holm S, Holven KB, Krogh-Sørensen K, Russell D, et al. Increased Systemic and Local Interleukin 9 Le-vels in Patients with Carotid and Coronary Atherosclerosis. PLoS One 2013; 8(8): e72769.

Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, et al. Selective probiotic bacteria induce IL-10–producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell–specific intercellular adhe-sion molecule 3–grabbing nonintegrin. J Allergy Clin Immunol 2005; 115(6): 1260−7.

Hahn C, Liewehr F. Relationships between Caries Bacteria, Host Responses, and Clinical Signs and Symptoms of Pulpitis. J Endod 2007; 33(3): 213−9.

Hahn CL, Best AM, Tew JG. Cytokine induction by Streptococ-cus mutans and pulpal pathogenesis. Infect Immun 2000; 68(12): 6785−9.

Naoum S, Martin E, Ellakwa A. Long-Term Fluoride Ex-changes at Restoration Surfaces and Effects on Surface Me-chanical Properties. ISRN Dent 2013; 2013: 579039.

Riksen EA, Kalvik A, Brookes S, Hynne A, Snead ML, Lyngstadaas SP, et al. Fluoride reduces the expression of ena-mel proteins and cytokines in an ameloblast-derived cell line. Arch Oral Biol 2011; 56(4): 324−30.

Kubota K, Lee DH, Tsuchiya M, Young CS, Everett ET, Martinez-Mier EA, et al. Fluoride Induces Endoplasmic Reticulum Stress in Ameloblasts Responsible for Dental Enamel Formation. J Biol Chem 2005; 280(24): 23194−202.

Afolabi OK, Oyewo EB, Adekunle AS, Adedosu OT, Adedeji AL. Oxidative indices correlate with dyslipidemia and pro-inflammatory cytokine levels in fluoride-exposed rats. Arh Hig Rada Toksikol 2013; 64(4): 521−9.

Huang TH, Yang CC, Ding SJ, Yeng M, Kao CT, Chou MY. In-flammatory cytokines reaction elicited by root-end filling mate-rials. J Biomed Mater Res B Appl Biomater 2005; 73(1): 123−8.

Björkman L, Brokstad KA, Moen K, Jonsson R. Minor changes in serum levels of cytokines after removal of amalgam restora-tions. Toxicol Lett 2012; 211(2): 120−5.

Fayazi S, Ostad SN, Razmi H. Effect of ProRoot MTA, Port-land cement, and amalgam on the expression of fibronectin, collagen I, and TGFβ by human periodontal ligament fibrob-lasts in vitro. Indian J Dent Res 2011; 22(2): 190−4.

Filho GJ, Cintra LT, Junior DE, Watanabe S, Faria MD, Gomes AC, et al. Effects of modified Portland cement and MTA on fibroblast viability and cytokine production. Dental Press En-dod 2012; 2(2): 20−24.

Barth KA, Waterfield JD, Brunette DM. The effect of surface roughness on RAW 264. macrophage phenotype. J Biomed Mater Res A 2013; 101(9): 2679−88.

Published
2017/03/03
Section
Original Paper